NFE2L2 and diabetes mellitus: Thus, we hypothesised that pathologically high GSK3 activity would impair NRF2-target gene expression in beta cells and contribute to loss of redox homeostasis during the pathogenesis of diabetes by increasing repression of NRF2 via the β-TrCP/GSK3 axis.